117 results
Page 6 of 6
424B5
stf12cbbpxbvemweu5qd
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-1.1
6rcqv09vq
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
goehi6ej1
6 Jun 18
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
yrw4m9u5xy1
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B4
ztp2ls30j5 dnzqn7
8 Apr 16
Prospectus supplement with pricing info
12:00am
10-K
07ihaoxajxrl28b8z
8 Mar 16
Annual report
12:00am
10-Q
dy7gr528
12 Jun 15
Quarterly report
12:00am
10-Q
EX-10.1
mk07 0mjro8kcsm5w2
12 Jun 15
Quarterly report
12:00am